» Articles » PMID: 6626419

Effects of Tobacco Smoking and Oral Contraceptive Use on Theophylline Disposition

Overview
Specialty Pharmacology
Date 1983 Sep 1
PMID 6626419
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The independent as well as interactive effects of chronic (greater than 6 months) oral contraceptive (OC) use and cigarette smoking on single-dose (4 mg/kg) theophylline disposition were assessed in 49 young, healthy women. Significant elevations (40%) in theophylline plasma clearance were found in women who smoked. OC use resulted in decreases in clearance of a similar magnitude (28%). These factors do not appear to interact with respect to theophylline disposition. The combination of main effects tended to cancel one another (clearance of 49.1 ml h-1 kg-1 ideal body weight for OC non-user, non-smoker, vs 49.7 ml h-1 kg-1 for OC user-smoker). Single dose exposure to OC in non-users did not significantly alter theophylline pharmacokinetics for the group as a whole. However, in the subgroup of smoking subjects, significant decreases in clearance were evident (P less than 0.05). Analogous results were found for half-life. Volume of distribution was slightly diminished in smokers, but was unaffected in OC users. Areas under the serum concentration-time (AUC) profiles of norgestrel and ethinyloestradiol were examined in 27 women as indices of OC exposure. The smallest values of theophylline clearance were found in the subjects with largest AUC of both OC steroids. Appropriate statistical analyses of data which are influenced by multiple factors are discussed. Special concern is needed when the factor partitioning process yields subgroups of unequal sizes.

Citing Articles

Clinical Relevance of Drug Interactions with Cannabis: A Systematic Review.

Lopera V, Rodriguez A, Amariles P J Clin Med. 2022; 11(5).

PMID: 35268245 PMC: 8911401. DOI: 10.3390/jcm11051154.


A Review of Cannabis in Chronic Kidney Disease Symptom Management.

Ho C, Martinusen D, Lo C Can J Kidney Health Dis. 2019; 6:2054358119828391.

PMID: 30828459 PMC: 6388458. DOI: 10.1177/2054358119828391.


Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Anderson G, Chan L Clin Pharmacokinet. 2016; 55(11):1353-1368.

PMID: 27106177 DOI: 10.1007/s40262-016-0400-9.


Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.

Gabriel L, Tod M, Goutelle S Clin Pharmacokinet. 2016; 55(8):977-90.

PMID: 26936044 DOI: 10.1007/s40262-016-0371-x.


Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).

Ogawa R, Stachnik J, Echizen H Clin Pharmacokinet. 2013; 52(3):169-85.

PMID: 23344981 DOI: 10.1007/s40262-012-0029-2.


References
1.
Mitoma C, LOMBROZO L, LeValley S, Dehn F . Nature of the effect of caffeine on the drug-metabolizing enzymes. Arch Biochem Biophys. 1969; 134(2):434-41. DOI: 10.1016/0003-9861(69)90303-8. View

2.
Carter D, Goldman J, BRESSLER R, Huxtable R, CHRISTIAN C, Heine M . Effect of oral contraceptives on drug metabolism. Clin Pharmacol Ther. 1974; 15(1):22-31. DOI: 10.1002/cpt197415122. View

3.
Cook C, Tallent C, Christensen H . Antigens from synthetic and natural estrogens: formation by conjugation with protein through a thiopropionic acid link. Life Sci. 1974; 14(6):1075-87. DOI: 10.1016/0024-3205(74)90232-x. View

4.
JENNE H, Nagasawa H, McHugh R, Macdonald F, Wyse E . Decreased theophylline half-life in cigarette smokers. Life Sci. 1975; 17(2):195-8. DOI: 10.1016/0024-3205(75)90503-2. View

5.
Stanczyk F, Hiroi M, Goebelsmann U, Brenner P, Lumkin M, Mishell Jr D . Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration. Contraception. 1975; 12(3):279-98. DOI: 10.1016/0010-7824(75)90088-8. View